Projects

“A really great program that has enabled several important contacts for our company and helped to grow as a entrepreneur.” Harri, Sartar Therapeutics
“Surgify received highly important expert advice and international networks from the SPARK Finland -program. This is the place-to-be for a starting medtech entrepreneur!”

 

SPARKees – our teams

See alumni teams
IndiviChip

Batch: Fall 2025

Automated microfluidic platform for activity-based screening of extracellular biomarkers

Contact person: Tiina Sikanen

    ICDx – Next-Generation Immunoassays for Hormone Diagnostics

    Batch: Fall 2025

    Highly sensitive and scalable immunoassay platform enabling accurate hormone testing for both centralized laboratories and future point-of-care applications

    Contact person: Teppo Hyytiä

      GenesMAP

      Batch: Fall 2025

      γPNA/MNAzyme as a new tool for rapid and sensitive gene detection in double-strand DNA

      Contact person: Hongbo Zhang

        Brain-Informed

        Batch: Spring 2025

        From traditional to neurophysiology-guided stroke rehabilitation — we are creating a tool to individualize motor rehabilitation based on each patient's unique functional brain reserve.

        Contact person: Miikkael Salmi

          AdCab

          Batch: Spring 2025

          We are targeting pancreatic cancer's Achilles heel with a groundbreaking and novel mechanism

          Contact person: Tuuli Ranki & Firas Hamdan

            Upcycling organic waste with earthworms

            Batch: Spring 2025

            We use transgenic earthworms to turn organic waste into high-value proteins, e.g. antibodies.

            Contact person: Michael Jeltsch

              Kudos – Cellular Twins

              Batch: Spring 2025

              We aim to create AI models that can diagnose diseases and predict drug efficacy from early-phase histological biopsies based on cellular morphology, whilst avoiding the need for expensive and time-consuming drug assays.

              Contact person: Minttu Polso

              Symptonic

              Batch: Spring 2025

              Developing an AI algorithm to remotely detect and monitor health indicators through analysis of speech signals

              Contact person: Mikko Petäjä

                B1 Coils

                Batch: Spring 2025

                Next generation radiofrequency coils to acquire more data from each MRI scan, enhancing diagnostic and treatment precision.

                Contact person: Denis Le Bras

                PreMet

                Batch: Spring 2025

                We develop a rapid, accurate, and predictive diagnostic platform for early-stage breast cancer and its metastasis.

                Contact person: Nonappa

                  Stop Seizures

                  Batch: Spring 2025

                  Stop Seizures project aims to develop a novel drug with a unique drug target for treating Epilepsy.

                  Contact person: Ushanandini Mohanraj

                    MyNeuroCure

                    Batch: Fall 2024

                    A novel & ground-breaking drug therapy for ALS

                    Contact person: Merja Voutilainen

                    DropByeDrop

                    Batch: Fall 2024

                    Simplifying Glaucoma Care: Monthly Eyedrops for Improved Patient Compliance

                    Contact person: Stanislav Kalinin

                    BrainFeat

                    Batch: Fall 2024

                    AI-based rapid feature extraction transforming medical big brain data into usable format

                    Contact person: Harri Merisaari

                    AR4U

                    Batch: Fall 2024

                    Developing an augmented reality solution to empower elderly individuals to live longer, healthier, and more active lives in their own homes.

                    Contact person: Timo Niskanen

                    Cornea Sense

                    Batch: Fall 2024

                    Cornea Sense aims to improve cornea health diagnostic by directly measuring cornea hydration levels for better patient outcomes and treatment

                    Contact person: Anton Chernenko

                    Immobilization stand

                    Batch: Fall 2024

                    A stand that allows easier casting and better performance in limb procedures.
                    (Link in Finnish)

                    Contact person: Pekka Nätti

                    NeuroEye Insight

                    Batch: Spring 2024

                    Opportunistic Screening of Alzheimer's Disease Using Retinal Imaging

                    Contact person: Sebastian Högnabba

                    DepMYC

                    Batch: Spring 2024

                    Developing MYC-dependency targeting drugs to treat cancer

                    Contact person: Juha Klefström

                    PREPARE

                    Batch: Spring 2024

                    Development of powerful protein-based vaccine technologies
                    Spin-out to Innofend Oy

                    Contact person: Minna Hankaniemi

                    OxyBioStroke

                    Batch: Spring 2024

                    A blood test for fast track to stroke treatment

                    Contact person: Helike Lõhelaid

                    ERresQ

                    Batch: Spring 2024

                    Development of novel cellular stress regulators for the treatment of neurological and metabolic diseases.
                    Spin-out to ERresQ Oy

                    Contact person: Vera Kovaleva

                    Im.Engine

                    Batch: Spring 2024

                    Pocket sized microscope that solves the challenges faced by research and diagnostic labs.

                    Contact person: Igor Shevkunov

                    KAJO Neurotechnologies

                    Batch: Fall 2023

                    Developing pathophysiologically relevant in vitro models for human neurodegenerative disorders for drug discovery
                    Turned into a drug development project.

                    Contact person: Mikko Airavaara

                    TrueScreen

                    Batch: Fall 2023

                    A novel, non-invasive approach for cancer screening and diagnosis

                    Contact person: Andrew Erickson

                    NAVIGATOR

                    Batch: Fall 2023

                    Developing and new tumour-specific agent designed to diagnose and treat metastatic brain tumours.

                    Contact person: Pirjo Laakkonen

                    Solid-IO

                    Batch: Fall 2023

                    Cancer immunotherapy testing on a chip.
                    Spin-out to Solid Immuno-Oncology Oy

                    Contact person: Heidi Haikala

                    MIOR Immunotherapy

                    Batch: Spring 2023

                    Developing new immunotherapies for cancer

                    Contact person: Carlos Rogerio Figueiredo

                    Immunoliposomes

                    Batch: Spring 2023

                    Immunoliposomes to detect rupture prone intracranial aneurysms

                    Contact person: Behnam Rezai Jahromi

                    Feanalytic

                    Batch: Spring 2023

                    Non-invasive method to diagnose intestinal diseases

                    Contact person: Lauri Polari

                    Vit3DAct

                    Batch: Spring 2023

                    Intra-articular calcipotriol for treatment of (osteo)arthritis

                    Contact person: Johanna Huhtakangas

                    Natal Mind

                    Batch: Spring 2023

                    Digital therapeutics treatment for fear of childbirth

                    Contact person: Annika Järvelin

                    Colorific

                    Batch: Spring 2023

                    DNA Nanoswitches-enabled Visual Colorimetric Diagnostics

                    Contact person: Jacky Loo

                    Glue4Life

                    Batch: Spring 2023

                    Next-generation bioinks for 3D bioprinting living tissues and organs.
                    Spin-out to LifeGlue Technologies Oy

                    Contact person: Anni Mörö

                    SanguID

                    Batch: Spring 2023

                    Improved early-stage cancer detection and sensitive disease monitoring
                    Project manager moved to University of Zurich.

                    Contact person: Pyry Helkkula

                    OTOS

                    Batch: Spring 2023

                    Early intervention for hearing health
                    Spin-out to Otos Health Oy

                    Contact person: Tanja Tervonen

                    INGA

                    Batch: Spring 2023

                    Novel method for optimized and personalized labor induction care

                    Contact person: Hanna Castrén-Niemi

                    Jedi BF R2B

                    Batch: Fall 2022

                    A smart optical sensor for arthroscopic surgery
                    Preparing spin-out to a startup.

                    Contact person: Isaac Afara

                    Mukava

                    Batch: Fall 2022

                    Graphene based dry electrodes for biometric measurements
                    Spin-out to Mukava Biosignals Oy

                    Contact person: Teemu Ruotsalainen

                    R2therapies

                    Batch: Fall 2022

                    Novel biomarker and early drug intervention for Alzheimer's disease

                    Spin-out to R2therapies Oy

                    Contact person: Ilkka Fagerlund

                      Surgerix

                      Batch: Fall 2022

                      (Former ER4Surgery) Image-guided surgery without Instruments.
                      Spin out to Surgerix Oy.

                      Contact person: Mikko Pitkänen

                      3D CelluGel

                      Batch: Fall 2022

                      A Novel Cell Growth Matrix by 3D Printing of Biopolymers

                      Contact person: Chunlin Xu

                      L-Cell

                      Batch: Spring 2022

                      Light- reconfigurable substrate for cell cultures

                      Contact person: Chiara Fedele

                      Brightlife

                      Batch: Spring 2022

                      Mental health platform and services

                      Spin-out to Brightlife Oy

                      Contact person: Eero Haikonen

                      COMITELL

                      Batch: Spring 2022

                      Delivery of encapsulated mitochondria as novel pharmaceutical solution

                      Contact person: Hongbo Zhang

                      Multivision Diagnostics

                      Batch: Spring 2022

                      Automated and scalable tool for precision diagnosis and personalized treatment
                      Spin-out to MultivisionDx Oy

                      Contact person: Karolina Punovuori

                      AIDHEART

                      Batch: Fall 2021

                      AI for the detection of heart transplant rejection.
                      Product validation continues, spin-out under consideration.

                      Contact person: Juha Peltonen

                      PAMO

                      Batch: Fall 2021

                      Novel method for diagnosing respiratory suppression
                      Spin-out to a non-published startup.

                      Contact person: Antti Vehkaoja

                      hentoTouch

                      Batch: Fall 2021

                      Non-invasive solution to support rehabilitation from AUD.
                      Spin-out to AlionLife Oy

                      Contact person: Jukka Planman

                      Urisens

                      Batch: Fall 2021

                      Diaper embedded biosensor platform, that screens abnormal clinical conditions

                      Contact person: Oguz Tanzer

                      Nosore

                      Batch: Fall 2021

                      Prevention of pressure ulcers
                      Manager was recruited as Team Leader to Attendo.

                      Contact person: Nuno Nobre

                      OrganAnalytics

                      Batch: Fall 2021

                      Viability analysis of organ transplants, and neuronal and cardiac implants
                      Preparing spin-out to a startup.

                      Contact person: Jarno Tanskanen

                      TumorMimic

                      Batch: Fall 2021

                      TumorMimic tailors 3D cultures to enable enhanced cancer drug screening

                      Contact person: Juho Pokki

                      GLOBEVAC

                      Batch: Fall 2021

                      How to make vaccines thermostable
                      Preparing to spin-out a startup.

                      Contact person: Manlio Fusciello

                      Proteabs

                      Batch: Spring 2021

                      Rapid diagnostics of human picornaviruses based on viral proteases

                      Contact person: Petri Susi

                      3DFluoHisto

                      Batch: Spring 2021

                      Novel method for histology.
                      Solution for commercial use at University of Turku.

                      Contact person: Ilkka Paatero

                      mTMS

                      Batch: Spring 2021

                      mTMS – multilocus transcranial magnetic stimulation.
                      Devices already in use at international pilot customers.

                      Contact person: Dubravko Kicic

                      Corflux

                      Batch: Spring 2021

                      Personalized prediction of the risk for aortic dilatation and rupture.
                      Preparing spin-out to a startup.

                      Contact person: Marja Hedman

                      JasminePro

                      Batch: Spring 2021

                      Poly(jasmine lactone): A Versatile Platform for Drug Delivery

                      Contact person: Kuldeep Bansal

                      MAIJU

                      Batch: 2020

                      Method for objective assessment of infant motor development.
                      Solution in use at BABA Center (HUS) and collaboration with Movesense.

                      Contact person: Sampsa Vanhatalo

                      DecoDerma

                      Batch: 2020

                      Tissue specific therapy for skin diseases.
                      Licensed to THERAVIA.

                      Contact person: Tero Järvinen

                      Integrated Secretion Solutions

                      Batch: 2020

                      Platform for optimized production of biotechnological proteins

                      Spin-out to Avenue Biosciences Oy and a startup in the U.S.

                      Contact person: Ville Paavilainen

                      MEG-MRI

                      Batch: 2020

                      Functional brain imaging reshaped

                      Contact person: Marko Havu

                      Wittify

                      Batch: 2020

                      Smart heart monitoring.

                      Spin-out to Sonai Health Oy.

                      Contact person: Arto Kotimaa

                      EpiHeart

                      Batch: 2020

                      Cardiac Micrograft Therapy™ for treating Ischhemic Scars and Heart Failure.

                      Spin-out to EpiHeart Oy.

                      Contact person: Kai Kronström

                      AccuQT

                      Batch: 2020

                      Accurate correction for QT interval ‒ the most important cardiac risk measure.
                      Spin-out to Monicardi Oy

                      Contact person: Esa Räsänen

                      Capsamedix

                      Batch: 2020

                      Long-term oral drug delivery.

                      Alumni due Prof. Helder Santos got recruited as Head of Biomedical Engineering at UMCG (Groningen, NED).

                      Contact person: Helder Santos

                      Anison

                      Batch: 2020

                      Natural medication for human papillomavirus (HPV)-associated warts.

                      Spin-out to ATB Antivirals Oy (previously Anison Therapeutics)

                      Contact person: Preethy Paul

                      Moncyte

                      Batch: 2020

                      Functional insight into hypercholesterolemia patients.
                      Spin-out to Moncyte Oy

                      Contact person: Simon Pfisterer

                      Algoa Progress

                      Batch: 2020

                      Personalized treatment planning of osteoarthritis.

                      Spin-out to MSK Technologies Oy.

                      Contact person: Joona Kemppainen

                      Solving the Mesh

                      Batch: 2020

                      Implantable support to treat pelvic organ prolapse.
                      Spin-out to Lignum Medical Oy

                      Contact person: Eija Raussi-Lehto

                      TOXELEGANS

                      Batch: 2020

                      Indoor air diagnostics with fluorescent C. elegans nematodes.

                      Lead to a co-research project.

                      Contact person: Päivi Koskinen

                      StemSight

                      Batch: 2019

                      Novel treatment for limbal epithelial stem cell deficiency.

                      Spin-out to StemSight Oy

                      Contact person: Laura Koivusalo

                      VIRI

                      Batch: 2019

                      Therapeutics for antimicrobial resistant bacteria.

                      Spin-out to Arivin Therapeutics Oy, was accepted to INCATE Incubator.

                      Contact person: Christopher Jonkergouw

                      FRACTAID

                      Batch: 2019

                      Distal radius fractures artificial intelligence diagnostic tool.
                      Preparations for a startup in progress.

                      Contact person: Jorma Ryhänen

                      AdvaNeedle

                      Batch: 2019

                      Ultrasound solution for cancer biopsies
                      Technology licensing under preparation.

                      Contact person: Jouni Rantanen

                      DropPen

                      Batch: 2019

                      Simple droplet devices for biomedicine, diagnostics and pharma.
                      Got continuing development funding.

                      Contact person: Päivi Saavalainen

                      VertiGoggles

                      Batch: 2019

                      Vertigo diagnostics for primary care.

                      Got remarkable funding for another project.

                      Contact person: Tuomas Hyytiä

                      NADMed

                      Batch: 2019

                      Diagnostic test for vitamin B3 metabolism deficiency.

                      Spin-out to NADMED Oy

                      Contact person: Liliya Euro

                      TopoCoating

                      Batch: 2019

                      Topographically tuned and sustainable surfaces for biological applications.

                      Potential licensing case. Project manager got recruited as Innovation Manager at UTU.

                      Contact person: Erik Niemelä

                      Liquid Biopsy Solutions

                      Batch: Fall 2018

                      Laboratory and computational method for liquid biopsies.
                      Spin-out to Genomill Health Oy

                      Contact person: Manu Tamminen

                      PPI Modulators

                      Batch: Fall 2018

                      Rational discovery of protein-protein interaction modulators.

                      Spin-out to Aurlide Oy

                      Contact person: Olli Pentikäinen

                      PARKS – Parkinson’s Biomarker Test

                      Batch: Fall 2018

                      Parkinson’s signature biomarker assay.
                      Ongoing large validation study with Michael J Fox Foundation funding.

                      Contact person: Eleanor Coffey

                      LightReactor

                      Batch: Spring 2018

                      Light controlled protein production.
                      An alumni due Project Manager got recruited to Bayer.

                      Contact person: Jari Rossi

                      Team Scheperjans

                      Batch: Spring 2018

                      Microbiome therapy for Parkinson’s disease.
                      IP turned into NeuroBiome Oy that has contract with a large company

                      Contact person: Filip Scheperjans

                      HemoCure

                      Batch: Spring 2018

                      Extra cellular vesicle solution for bleeding disorders.
                      An alumni due Project Manager got recruited to Mayo Clinic (USA).

                      Contact person: Mayank Saraswat

                      FastEV

                      Batch: Spring 2018

                      Method for extra-cellular vesicle (EV) isolation.
                      Solution in use at EV group at University of Helsinki.

                      Contact person: Maija Puhka

                      Heart4Oxygen

                      Batch: Spring 2018

                      Method to monitor the oxygenation of myocardial tissue.
                      Spin-out to SpectroCor Oy

                      Contact person: Kalle Kotilahti

                      Maculaser

                      Batch: Spring 2018

                      Novel heat treatment for age related macular degeneration.
                      Spin-out to Maculaser Oy

                      Contact person: Jani Tirronen

                      Team Scheperjans

                      Batch: Spring 2018

                      Microbiome diagnostics for Parkinson’s disease.
                      IP turned to NeuroBiome Oy that has joint development and licensing agreement.

                      Contact person: Filip Scheperjans

                      TB Biofilm

                      Batch: Spring 2018

                      Mycobacterial biofilms as anti-tuberculosis drug targets.
                      Became a cornerstone of an extensive multinational research program.

                      Contact person: Mataleena Parikka

                      SCELLOMICS

                      Batch: Spring 2018

                      Novel single cell omics methods.
                      Spin-out to Scellex Oy

                      Contact person: Päivi Saavalainen

                      LASU

                      Batch: Spring 2018

                      Light-activated antimicrobial surfaces and materials.
                      IP acquired by Plasmonics Oy

                      Contact person: Alexandre Efimov

                      NEXTCAST

                      Batch: Fall 2017

                      AI solution for toxicity testing.

                      Solution in use at FHAIVE, a reference toxicity laboratory for EURL ECVAM.

                      Contact person: Dario Greco

                      EyeLase

                      Batch: Fall 2017

                      Laser solution for eye treatment.

                      Became a development case for industry.

                      Contact person: Jukka Viheriälä

                      HuManCardio

                      Batch: Fall 2017

                      Toxicity test for heart cells.

                      Solution in use at FHAIVE, a reference toxicity laboratory for EURL ECVAM.

                      Contact person: Tuula Heinonen

                      Olfactomics

                      Batch: Fall 2017

                      Tissue analysis for breast cancer surgery.
                      Spin-out to Olfactomics Oy

                      Contact person: Antti Roine

                      Ocular Surface Precision Panel

                      Batch: Spring 2017

                      Ocular biomarker panel and analysis.
                      Project manager got recruited to another project.

                      Contact person: Ulla Aapola

                      GreenSeq/ Seqnom

                      Batch: Spring 2017

                      Microbiological Analyses on (Blue) Bio- and Circular Economies.
                      Spin-out to GreenSeq Oy

                      Contact person: Kirsi-Maarit Lehto

                      SMART PD

                      Batch: Spring 2017

                      Peritoneal diagnostics for dialysis patients.
                      Spin-out to Kiwecare / Smart PD Solutions Oy

                      Contact person: Pirgit Silvast-Äikäs

                      SEBI-Group

                      Batch: Pilot 2016 / Spring 2017

                      Nano structure for bioimaging.
                      Spin-out to XFold Imaging Oy

                      Contact person: Timo Jäntti

                      Sartar

                      Batch: Pilot 2016 / Spring 2017

                      Cancer drug for GIST.
                      Spin out to Sartar Therapeutics Oy

                      Contact person: Harri Sihto

                      iDenta

                      Batch: Pilot 2016 / Spring 2017

                      Caries and infection prevention and treatment.

                      Spin-out to Koite Health Oy

                      Contact person: Tommi Pätilä

                      Surgify

                      Batch: Pilot 2016 / Spring 2017

                      Safety mechanism for surgical drills.

                      Spin-out to Surgify Medical Oy

                      Contact person: Visa Sippola

                      Alumni

                      Team Scheperjans

                      Batch: Spring 2018

                      Microbiome therapy for Parkinson’s disease.
                      IP turned into NeuroBiome Oy that has contract with a large company

                      Contact person: Filip Scheperjans

                      Olfactomics

                      Batch: Fall 2017

                      Tissue analysis for breast cancer surgery.
                      Spin-out to Olfactomics Oy

                      Contact person: Antti Roine

                      SEBI-Group

                      Batch: Pilot 2016 / Spring 2017

                      Nano structure for bioimaging.
                      Spin-out to XFold Imaging Oy

                      Contact person: Timo Jäntti

                      iDenta

                      Batch: Pilot 2016 / Spring 2017

                      Caries and infection prevention and treatment.

                      Spin-out to Koite Health Oy

                      Contact person: Tommi Pätilä

                      Surgify

                      Batch: Pilot 2016 / Spring 2017

                      Safety mechanism for surgical drills.

                      Spin-out to Surgify Medical Oy

                      Contact person: Visa Sippola

                      Liquid Biopsy Solutions

                      Batch: Fall 2018

                      Laboratory and computational method for liquid biopsies.
                      Spin-out to Genomill Health Oy

                      Contact person: Manu Tamminen

                      PPI Modulators

                      Batch: Fall 2018

                      Rational discovery of protein-protein interaction modulators.

                      Spin-out to Aurlide Oy

                      Contact person: Olli Pentikäinen

                      LightReactor

                      Batch: Spring 2018

                      Light controlled protein production.
                      An alumni due Project Manager got recruited to Bayer.

                      Contact person: Jari Rossi

                      HemoCure

                      Batch: Spring 2018

                      Extra cellular vesicle solution for bleeding disorders.
                      An alumni due Project Manager got recruited to Mayo Clinic (USA).

                      Contact person: Mayank Saraswat

                      SCELLOMICS

                      Batch: Spring 2018

                      Novel single cell omics methods.
                      Spin-out to Scellex Oy

                      Contact person: Päivi Saavalainen

                      EyeLase

                      Batch: Fall 2017

                      Laser solution for eye treatment.

                      Became a development case for industry.

                      Contact person: Jukka Viheriälä

                      SMART PD

                      Batch: Spring 2017

                      Peritoneal diagnostics for dialysis patients.
                      Spin-out to Kiwecare / Smart PD Solutions Oy

                      Contact person: Pirgit Silvast-Äikäs

                      Sartar

                      Batch: Pilot 2016 / Spring 2017

                      Cancer drug for GIST.
                      Spin out to Sartar Therapeutics Oy

                      Contact person: Harri Sihto

                      VertiGoggles

                      Batch: 2019

                      Vertigo diagnostics for primary care.

                      Got remarkable funding for another project.

                      Contact person: Tuomas Hyytiä

                      FastEV

                      Batch: Spring 2018

                      Method for extra-cellular vesicle (EV) isolation.
                      Solution in use at EV group at University of Helsinki.

                      Contact person: Maija Puhka

                      Heart4Oxygen

                      Batch: Spring 2018

                      Method to monitor the oxygenation of myocardial tissue.
                      Spin-out to SpectroCor Oy

                      Contact person: Kalle Kotilahti

                      Maculaser

                      Batch: Spring 2018

                      Novel heat treatment for age related macular degeneration.
                      Spin-out to Maculaser Oy

                      Contact person: Jani Tirronen

                      TB Biofilm

                      Batch: Spring 2018

                      Mycobacterial biofilms as anti-tuberculosis drug targets.
                      Became a cornerstone of an extensive multinational research program.

                      Contact person: Mataleena Parikka

                      LASU

                      Batch: Spring 2018

                      Light-activated antimicrobial surfaces and materials.
                      IP acquired by Plasmonics Oy

                      Contact person: Alexandre Efimov

                      HuManCardio

                      Batch: Fall 2017

                      Toxicity test for heart cells.

                      Solution in use at FHAIVE, a reference toxicity laboratory for EURL ECVAM.

                      Contact person: Tuula Heinonen

                      Ocular Surface Precision Panel

                      Batch: Spring 2017

                      Ocular biomarker panel and analysis.
                      Project manager got recruited to another project.

                      Contact person: Ulla Aapola

                      GreenSeq/ Seqnom

                      Batch: Spring 2017

                      Microbiological Analyses on (Blue) Bio- and Circular Economies.
                      Spin-out to GreenSeq Oy

                      Contact person: Kirsi-Maarit Lehto

                      EpiHeart

                      Batch: 2020

                      Cardiac Micrograft Therapy™ for treating Ischhemic Scars and Heart Failure.

                      Spin-out to EpiHeart Oy.

                      Contact person: Kai Kronström

                      Capsamedix

                      Batch: 2020

                      Long-term oral drug delivery.

                      Alumni due Prof. Helder Santos got recruited as Head of Biomedical Engineering at UMCG (Groningen, NED).

                      Contact person: Helder Santos

                      Anison

                      Batch: 2020

                      Natural medication for human papillomavirus (HPV)-associated warts.

                      Spin-out to ATB Antivirals Oy (previously Anison Therapeutics)

                      Contact person: Preethy Paul

                      Algoa Progress

                      Batch: 2020

                      Personalized treatment planning of osteoarthritis.

                      Spin-out to MSK Technologies Oy.

                      Contact person: Joona Kemppainen

                      StemSight

                      Batch: 2019

                      Novel treatment for limbal epithelial stem cell deficiency.

                      Spin-out to StemSight Oy

                      Contact person: Laura Koivusalo

                      TopoCoating

                      Batch: 2019

                      Topographically tuned and sustainable surfaces for biological applications.

                      Potential licensing case. Project manager got recruited as Innovation Manager at UTU.

                      Contact person: Erik Niemelä

                      Team Scheperjans

                      Batch: Spring 2018

                      Microbiome diagnostics for Parkinson’s disease.
                      IP turned to NeuroBiome Oy that has joint development and licensing agreement.

                      Contact person: Filip Scheperjans

                      NEXTCAST

                      Batch: Fall 2017

                      AI solution for toxicity testing.

                      Solution in use at FHAIVE, a reference toxicity laboratory for EURL ECVAM.

                      Contact person: Dario Greco

                      Wittify

                      Batch: 2020

                      Smart heart monitoring.

                      Spin-out to Sonai Health Oy.

                      Contact person: Arto Kotimaa

                      Solving the Mesh

                      Batch: 2020

                      Implantable support to treat pelvic organ prolapse.
                      Spin-out to Lignum Medical Oy

                      Contact person: Eija Raussi-Lehto

                      TOXELEGANS

                      Batch: 2020

                      Indoor air diagnostics with fluorescent C. elegans nematodes.

                      Lead to a co-research project.

                      Contact person: Päivi Koskinen

                      VIRI

                      Batch: 2019

                      Therapeutics for antimicrobial resistant bacteria.

                      Spin-out to Arivin Therapeutics Oy, was accepted to INCATE Incubator.

                      Contact person: Christopher Jonkergouw

                      FRACTAID

                      Batch: 2019

                      Distal radius fractures artificial intelligence diagnostic tool.
                      Preparations for a startup in progress.

                      Contact person: Jorma Ryhänen

                      AdvaNeedle

                      Batch: 2019

                      Ultrasound solution for cancer biopsies
                      Technology licensing under preparation.

                      Contact person: Jouni Rantanen

                      DropPen

                      Batch: 2019

                      Simple droplet devices for biomedicine, diagnostics and pharma.
                      Got continuing development funding.

                      Contact person: Päivi Saavalainen

                      NADMed

                      Batch: 2019

                      Diagnostic test for vitamin B3 metabolism deficiency.

                      Spin-out to NADMED Oy

                      Contact person: Liliya Euro

                      PARKS – Parkinson’s Biomarker Test

                      Batch: Fall 2018

                      Parkinson’s signature biomarker assay.
                      Ongoing large validation study with Michael J Fox Foundation funding.

                      Contact person: Eleanor Coffey

                      Brightlife

                      Batch: Spring 2022

                      Mental health platform and services

                      Spin-out to Brightlife Oy

                      Contact person: Eero Haikonen

                      Integrated Secretion Solutions

                      Batch: 2020

                      Platform for optimized production of biotechnological proteins

                      Spin-out to Avenue Biosciences Oy and a startup in the U.S.

                      Contact person: Ville Paavilainen

                      MEG-MRI

                      Batch: 2020

                      Functional brain imaging reshaped

                      Contact person: Marko Havu

                      KAJO Neurotechnologies

                      Batch: Fall 2023

                      Developing pathophysiologically relevant in vitro models for human neurodegenerative disorders for drug discovery
                      Turned into a drug development project.

                      Contact person: Mikko Airavaara

                      Natal Mind

                      Batch: Spring 2023

                      Digital therapeutics treatment for fear of childbirth

                      Contact person: Annika Järvelin

                      Glue4Life

                      Batch: Spring 2023

                      Next-generation bioinks for 3D bioprinting living tissues and organs.
                      Spin-out to LifeGlue Technologies Oy

                      Contact person: Anni Mörö

                      SanguID

                      Batch: Spring 2023

                      Improved early-stage cancer detection and sensitive disease monitoring
                      Project manager moved to University of Zurich.

                      Contact person: Pyry Helkkula

                      Jedi BF R2B

                      Batch: Fall 2022

                      A smart optical sensor for arthroscopic surgery
                      Preparing spin-out to a startup.

                      Contact person: Isaac Afara

                      Mukava

                      Batch: Fall 2022

                      Graphene based dry electrodes for biometric measurements
                      Spin-out to Mukava Biosignals Oy

                      Contact person: Teemu Ruotsalainen

                      3D CelluGel

                      Batch: Fall 2022

                      A Novel Cell Growth Matrix by 3D Printing of Biopolymers

                      Contact person: Chunlin Xu

                      PAMO

                      Batch: Fall 2021

                      Novel method for diagnosing respiratory suppression
                      Spin-out to a non-published startup.

                      Contact person: Antti Vehkaoja

                      hentoTouch

                      Batch: Fall 2021

                      Non-invasive solution to support rehabilitation from AUD.
                      Spin-out to AlionLife Oy

                      Contact person: Jukka Planman

                      Nosore

                      Batch: Fall 2021

                      Prevention of pressure ulcers
                      Manager was recruited as Team Leader to Attendo.

                      Contact person: Nuno Nobre

                      OrganAnalytics

                      Batch: Fall 2021

                      Viability analysis of organ transplants, and neuronal and cardiac implants
                      Preparing spin-out to a startup.

                      Contact person: Jarno Tanskanen

                      GLOBEVAC

                      Batch: Fall 2021

                      How to make vaccines thermostable
                      Preparing to spin-out a startup.

                      Contact person: Manlio Fusciello

                      3DFluoHisto

                      Batch: Spring 2021

                      Novel method for histology.
                      Solution for commercial use at University of Turku.

                      Contact person: Ilkka Paatero

                      mTMS

                      Batch: Spring 2021

                      mTMS – multilocus transcranial magnetic stimulation.
                      Devices already in use at international pilot customers.

                      Contact person: Dubravko Kicic

                      Corflux

                      Batch: Spring 2021

                      Personalized prediction of the risk for aortic dilatation and rupture.
                      Preparing spin-out to a startup.

                      Contact person: Marja Hedman

                      JasminePro

                      Batch: Spring 2021

                      Poly(jasmine lactone): A Versatile Platform for Drug Delivery

                      Contact person: Kuldeep Bansal

                      MAIJU

                      Batch: 2020

                      Method for objective assessment of infant motor development.
                      Solution in use at BABA Center (HUS) and collaboration with Movesense.

                      Contact person: Sampsa Vanhatalo

                      DecoDerma

                      Batch: 2020

                      Tissue specific therapy for skin diseases.
                      Licensed to THERAVIA.

                      Contact person: Tero Järvinen

                      AccuQT

                      Batch: 2020

                      Accurate correction for QT interval ‒ the most important cardiac risk measure.
                      Spin-out to Monicardi Oy

                      Contact person: Esa Räsänen

                      Moncyte

                      Batch: 2020

                      Functional insight into hypercholesterolemia patients.
                      Spin-out to Moncyte Oy

                      Contact person: Simon Pfisterer

                      PREPARE

                      Batch: Spring 2024

                      Development of powerful protein-based vaccine technologies
                      Spin-out to Innofend Oy

                      Contact person: Minna Hankaniemi

                      ERresQ

                      Batch: Spring 2024

                      Development of novel cellular stress regulators for the treatment of neurological and metabolic diseases.
                      Spin-out to ERresQ Oy

                      Contact person: Vera Kovaleva

                      Solid-IO

                      Batch: Fall 2023

                      Cancer immunotherapy testing on a chip.
                      Spin-out to Solid Immuno-Oncology Oy

                      Contact person: Heidi Haikala

                      OTOS

                      Batch: Spring 2023

                      Early intervention for hearing health
                      Spin-out to Otos Health Oy

                      Contact person: Tanja Tervonen

                      Surgerix

                      Batch: Fall 2022

                      (Former ER4Surgery) Image-guided surgery without Instruments.
                      Spin out to Surgerix Oy.

                      Contact person: Mikko Pitkänen

                      Multivision Diagnostics

                      Batch: Spring 2022

                      Automated and scalable tool for precision diagnosis and personalized treatment
                      Spin-out to MultivisionDx Oy

                      Contact person: Karolina Punovuori

                      AIDHEART

                      Batch: Fall 2021

                      AI for the detection of heart transplant rejection.
                      Product validation continues, spin-out under consideration.

                      Contact person: Juha Peltonen